A detailed history of Neo Ivy Capital Management transactions in Walgreens Boots Alliance, Inc. stock. As of the latest transaction made, Neo Ivy Capital Management holds 7,673 shares of WBA stock, worth $85,170. This represents 0.45% of its overall portfolio holdings.

Number of Shares
7,673
Holding current value
$85,170
% of portfolio
0.45%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 23, 2024

BUY
$19.94 - $26.64 $152,999 - $204,408
7,673 New
7,673 $200,000
Q3 2022

Nov 15, 2022

SELL
$31.4 - $42.04 $48,827 - $65,372
-1,555 Reduced 30.24%
3,587 $113,000
Q2 2022

Aug 16, 2022

BUY
$37.9 - $46.81 $194,881 - $240,697
5,142 New
5,142 $194,000
Q4 2021

Feb 15, 2022

SELL
$43.72 - $52.25 $101,736 - $121,585
-2,327 Closed
0 $0
Q3 2021

Nov 16, 2021

SELL
$45.58 - $51.78 $394,722 - $448,414
-8,660 Reduced 78.82%
2,327 $99,000
Q2 2021

Aug 16, 2021

SELL
$50.84 - $56.8 $204,478 - $228,449
-4,022 Reduced 26.8%
10,987 $578,000
Q1 2021

Oct 07, 2021

BUY
$41.16 - $55.05 $448,890 - $600,375
10,906 Added 265.81%
15,009 $824,000
Q4 2020

Feb 16, 2021

BUY
$33.52 - $44.1 $137,532 - $180,942
4,103 New
4,103 $164,000
Q3 2020

Nov 17, 2020

SELL
$34.67 - $43.16 $915,981 - $1.14 Million
-26,420 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$38.35 - $47.02 $923,966 - $1.13 Million
24,093 Added 1035.37%
26,420 $1.12 Million
Q2 2020

Aug 17, 2020

SELL
$38.35 - $47.02 $63,852 - $78,288
-1,665 Reduced 41.71%
2,327 $99,000
Q1 2020

May 15, 2020

BUY
$41.02 - $59.59 $163,751 - $237,883
3,992 New
3,992 $183,000
Q3 2019

Nov 21, 2019

SELL
$49.29 - $58.06 $1.3 Million - $1.53 Million
-26,420 Closed
0 $0
Q2 2019

Aug 15, 2019

BUY
$49.34 - $63.49 $1.3 Million - $1.68 Million
26,420 New
26,420 $1.44 Million

Others Institutions Holding WBA

About Walgreens Boots Alliance, Inc.


  • Ticker WBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Pharmaceutical Retailers
  • Shares Outstandng 864,812,992
  • Market Cap $9.6B
  • Description
  • Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products...
More about WBA
Track This Portfolio

Track Neo Ivy Capital Management Portfolio

Follow Neo Ivy Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Neo Ivy Capital Management with notifications on news.